|
14 Aug 2020 |
AstraZeneca concludes agreement with the European Commission for the supply of up to 400 million doses of AZD1222 COVID-19 vaccine
|
|
13 Aug 2020 |
Heat Biologic's COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies
|
|
12 Aug 2020 |
Vaccibody AS and Nektar Therapeutics Announce First Patient Dosed in a Phase 1/2a Study Arm Evaluating VB10.NEO, a Personalized Neoantigen Cancer Vaccine, with Bempegaldesleukin (NKTR-214) in Patients with Squamous Cell Carcinoma of the Head and Neck
|
|
11 Aug 2020 |
Arcturus Therapeutics Announces that it has Initiated Dosing of its COVID-19 STARR™ mRNA Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 study
|
|
10 Aug 2020 |
Vaxart Announces IND Filed for COVID-19 Vaccine
|
|
10 Aug 2020 |
GeneCure Biotechnologies launches first-in-human therapeutic vaccine to treat Covid-19 patients
|
|
10 Aug 2020 |
BIOQUAL Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of an mRNA Vaccine Against COVID-19 (mRNA-1273)
|
|
07 Aug 2020 |
Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan: Takeda
|
|
07 Aug 2020 |
Novavax and Serum Institute of India Announce Development and Commercial Collaboration
|
|
06 Aug 2020 |
IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study
|
|
06 Aug 2020 |
VBI Vaccines Awarded Up to CAD$56 Million Contribution from Canadian Government to Accelerate Coronavirus Vaccine Development
|
|
06 Aug 2020 |
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
|
|
05 Aug 2020 |
BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
|
|
05 Aug 2020 |
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
|
|
05 Aug 2020 |
Zydus Cadila Announces Completion of Dosing in Phase I Clinical Trial of ZyCoV-D
|
|
04 Aug 2020 |
DBV Technologies Receives Complete Response Letter from FDA for Viaskin Peanut BLA in Children Ages 4-11 Years
|
|
03 Aug 2020 |
ImmunityBio Study Shows Positive T Cell and Antibody Immune Responses to its COVID-19 Vaccine Candidate that Targets Both Spike and Nucleocapsid Virus Proteins
|
|
02 Aug 2020 |
Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate
|
|
31 Jul 2020 |
Sanofi and GSK selected for Operation Warp Speed to supply United States Government with 100 million doses of COVID-19 vaccine
|
|
31 Jul 2020 |
BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo® (cemiplimab) Combination in Melanoma
|
|
31 Jul 2020 |
Enterome initiates first clinical trial with EO2401 - an innovative microbiome-antigen ('OncoMimic') based cancer immunotherapy candidate targeting aggressive brain cancer
|
|
31 Jul 2020 |
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus
|
|
30 Jul 2020 |
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
|
|
29 Jul 2020 |
Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies
|
|
29 Jul 2020 |
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine
|
